LD
BRKR icon

Lipe & Dalton’s Bruker BRKR Stock Holding History

Lipe & Dalton’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,067
Closed -$519K – 101
2022
Q1 		$519K Buy
8,067
+1
+0% +$68 0.25% 58
2021
Q4 		$677K Sell
8,066
-200
-2% -$16K 0.32% 57
2021
Q3 		$646K Sell
8,266
-100
-1% -$8.31K 0.33% 56
2021
Q2 		$636K Buy
8,366
+200
+2% +$14K 0.33% 56
2021
Q1 		$525K Sell
8,166
-425
-5% -$25.5K 0.29% 55
2020
Q4 		$465K Buy
8,591
+1,325
+18% +$63.5K 0.29% 53
2020
Q3 		$289K Sell
7,266
-1,200
-14% -$50K 0.2% 63
2020
Q2 		$344K Buy
8,466
+1
+0% +$39 0.25% 58
2020
Q1 		$304K Sell
8,465
-325
-4% -$15.1K 0.26% 58
2019
Q4 		$448K Buy
8,790
+1,125
+15% +$53.6K 0.3% 54
2019
Q3 		$337K Buy
+7,665
New +$344K 0.25% 56

Other funds holding BRKR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Lipe & Dalton's BRKR Position: Q2 2022 in Review

Lipe & Dalton sold out of Bruker (BRKR) in Q2 2022, closing a stake of 8,067 shares — an estimated $519K sold.

Lipe & Dalton first reported a position in BRKR in Q3 2019 and held it in 11 quarters. The position peaked at $677K in Q4 2021. 296 funds tracked by Wall St. Rank hold BRKR as of Q2 2022.

  • Lipe & Dalton reported no remaining Bruker position as of Q2 2022 after selling out during the quarter.
  • Lipe & Dalton sold 8,067 Bruker shares in Q2 2022, an estimated $519K.
  • Lipe & Dalton first reported a position in Bruker in Q3 2019 and held it in 11 quarters.
  • Lipe & Dalton's Bruker position peaked at $677K in Q4 2021.
  • 296 funds tracked by Wall St. Rank held Bruker as of Q2 2022.

Based on Lipe & Dalton's 13F filing for Q2 2022, filed 1 Aug 2022.